Skinvisible Stock Forecast, Price & News

-0.07 (-45.45 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: $0.08
50-Day Range
MA: $0.13
52-Week Range
Now: $0.08
Volume100 shs
Average Volume4,548 shs
Market Capitalization$375,648.00
P/E RatioN/A
Dividend YieldN/A
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and others markets. The company offers sunless tanning and sunscreen products. Skinvisible, Inc. also licenses its products to manufacturers and marketers of brands internationally, as well as sells directly in the market; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was founded in 1998 and is based in Las Vegas, Nevada.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:SKVI
Year FoundedN/A



Sales & Book Value

Annual Sales$40,000.00
Book Value($1.04) per share


Net Income$-1,700,000.00
Net Margins-1,027.05%


Market Cap$375,648.00
Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.73 out of 5 stars

Medical Sector

1246th out of 2,025 stocks

Pharmaceutical Preparations Industry

551st out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
-0.07 (-45.45 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SKVI News and Ratings via Email

Sign-up to receive the latest news and ratings for SKVI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Skinvisible (OTCMKTS:SKVI) Frequently Asked Questions

What stocks does MarketBeat like better than Skinvisible?

Wall Street analysts have given Skinvisible a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Skinvisible wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Skinvisible's stock been impacted by Coronavirus (COVID-19)?

Skinvisible's stock was trading at $0.0495 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SKVI shares have increased by 69.7% and is now trading at $0.0840.
View which stocks have been most impacted by COVID-19

Who are Skinvisible's key executives?

Skinvisible's management team includes the following people:
  • Mr. Terry H. Howlett, Pres, CEO, CFO, Principal Accounting Officer & Director (Age 73, Pay $180k)
  • Ms. Doreen McMorran, Head of Bus. Devel. (Age 59)
  • Dr. Geert Cauwenbergh, Head of International Advisory Board (Age 67)

Who are some of Skinvisible's key competitors?

What other stocks do shareholders of Skinvisible own?

What is Skinvisible's stock symbol?

Skinvisible trades on the OTCMKTS under the ticker symbol "SKVI."

How do I buy shares of Skinvisible?

Shares of SKVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Skinvisible's stock price today?

One share of SKVI stock can currently be purchased for approximately $0.08.

How much money does Skinvisible make?

Skinvisible has a market capitalization of $375,648.00 and generates $40,000.00 in revenue each year.

How many employees does Skinvisible have?

Skinvisible employs 3 workers across the globe.

What is Skinvisible's official website?

The official website for Skinvisible is www.skinvisible.com.

Where are Skinvisible's headquarters?

Skinvisible is headquartered at 6320 S SANDHILL ROAD SUITE 10, LAS VEGAS NV, 89120.

How can I contact Skinvisible?

Skinvisible's mailing address is 6320 S SANDHILL ROAD SUITE 10, LAS VEGAS NV, 89120. The company can be reached via phone at 702-433-7154 or via email at [email protected]

This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.